-
Innovation Ranking
NewInnovation Ranking – Xenetic Biosciences Inc
Xenetic Biosciences Inc (Xenetic Biosciences), formerly General Sales & Leasing Inc, is a biopharmaceutical company. It discovers and develops biologic drugs and novel orphan oncology therapeutics. Its pipeline products include Virexxa, ErepoXen, and OncoHist. Xenetic Biosciences' lead product candidate ErepoXen is a polysialylated form of erythropoietin used to treat anemia in pre-dialysis patients with chronic kidney disease. The company’s Virexxa and OncoHist are used for the treatment of progesterone receptor negative endometrial cancer and refractory acute myeloid leukemia. It also...
-
Company Profile
Xenetic Biosciences Inc – Company Profile
Xenetic Biosciences Inc (Xenetic Biosciences), formerly General Sales & Leasing Inc, is a biopharmaceutical company. It discovers and develops biological drugs and novel orphan oncology therapeutics. The company’s product pipeline includes Systemic Dnase I + Chemo, Systemic Dnase I + Icis, Systemic Dnase I + Car T and Dnase-Armored Car T. Its pipeline candidates treat pancreatic carcinoma and solid tumors. Xenetic Biosciences Virexxa and OncoHist and ErepoXen are used for the treatment of progesterone receptor-negative endometrial cancer and refractory acute...
Add to Basket -
Product Insights
Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Renal anemia is a disease in which the patient has an unusually low count of red blood cells. Renal is a term that means the kidneys, so anemia is often associated with kidney disease. This type of anemia is caused by a lack of erythropoietin, a protein produced in the kidneys that helps to create red blood cells. Symptoms caused by renal anemia include pale skin and gums, become short of breath, dizziness, and inability to think clearly. The renal...
-
Product Insights
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Symptoms may include night sweats, fever and chills that come and go, itching, putting pressure on the windpipe (trachea) or other airways, abdominal pain or swelling, leading to loss of appetite, constipation, nausea, and vomiting and headache, concentration problems, personality changes, or seizures if cancer affects the brain. Treatment includes surgery,...
-
Product Insights
Endometrial Cancer Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Endometrial Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
PharmaPoint: Hemophilia A and B – Global Drug Forecast and Market Analysis to 2026
Hemophilia A and B are rare recessive X-linked genetic deficiencies in the blood clotting factors VIII and IX, respectively, and are characterized by the failure of blood to form normal clots after damage to veins and tissue. In the 7MM, patients with severe forms of the disease are increasingly treated on a prophylactic basis rather than on demand after bleeds. The frequent prophylactic infusions of rFVIII or rFIX begin from the first one or two years of life, often continuing...
-
Sector Analysis
Competitor Landscape: Renal Anemia
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Renal Anemia market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Product Insights
Endometrial Cancer Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Endometrial Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016" provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Anemia in Chronic Kidney Disease (Renal Anemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...